Brighter

Brighter AB was a Swedish health-tech company founded in 2007, which focused on developing solutions for chronic disease management, particularly diabetes. The company's vision was to simplify the lives of patients by creating data-centric tools that facilitate the flow of treatment data between patients, their families, and healthcare providers. Brighter's flagship product was Actiste, a device that combined blood glucose measurement and insulin injection into a single unit, automatically logging and sharing the data through a cloud service. The company operated on a subscription-based model called "Diabetes Management as a Service."

The company was founded by Truls Sjöstedt, who served as CEO until 2019 when he became Executive Chairperson of the Board, and Henrik Norström took over as CEO. Brighter was publicly listed on the Nasdaq First North Growth Market. Over the years, the company expanded its focus to include welfare technology and digital healthcare services through acquisitions, such as Nectarine Health, which specialized in AI-based monitoring solutions for elderly care. In 2019, Brighter won the Swecare Rising Stars Award for its contributions to healthcare.

Despite its product development and market expansion efforts, Brighter faced significant financial challenges. In November 2022, after a period of corporate restructuring failed to secure long-term financing, the company's board filed for bankruptcy. The decision was influenced by pandemic-related effects and a difficult macroeconomic climate. Subsequently, the Solna District Court approved the bankruptcy application, and Brighter's shares were delisted from the Nasdaq First North Growth Market with immediate effect on November 23, 2022. The company had also faced scrutiny from Nasdaq's Disciplinary Committee for breaching market rules between 2020 and 2022, resulting in a substantial fine.

Keywords: health-tech, diabetes management, medical device, Actiste, chronic disease, digital health, insulin treatment, remote patient monitoring, data-centric healthcare, welfare technology, Nectarine Health, Camanio, corporate restructuring, bankruptcy, delisted, Nasdaq First North